Rubio-Correa I, Manzano-Solo-de-Zaldívar D, Moreno-Sánchez M, C Hernández-Vila, Ramírez-Pérez FA, González-Ballester D Et al. Functional reconstruction after subtotal glossectomy in the surgical treatment of an uncommon and aggressive neoplasm in this location: Primary malignant melanoma in the base of the tongue. J Clin Exp Dent. 2014;6(4):e451-4.

doi:10.4317/jced.51606

http://dx.doi.org/doi:10.4317/jced.51606

References

1. Gutman M, Inbar M, Chaitchik S, Merhav A, Pausner D, Skoznik Y, Ilie B, Rozin RR, Klausner JM. Malignant melanoma of the mucous membranes. Eur J Surg Oncol. 1992;18:307-12.

PMid:1521620

2. Moore ES, Martin H: Melanoma of the upper respiratory tract and oral cavity. Cancer. 1955;8:1167-76.

http://dx.doi.org/10.1002/1097-0142(1955)8:6<1167::AID-CNCR2820080613>3.0.CO;2-I

PMid: 13270234

3. Rapini RP, Golitz LE, Greer RO Jr, Krekorian EA, Poulson T. Primary malignant melanoma of the oral cavity: A review of 177 cases. Cancer. 1985;55:1543-51.

http://dx.doi.org/10.1002/1097-0142(19850401)55:7<1543::AID-CNCR2820550722>3.0.CO;2-F

PMid: 3978548

4. Chiu TT, Lin HC, Su CY, Huang CC. Primary Malignant Melanoma of the Tongue. Chang Gung Med J. 2002;25:764-8.

PMid:12553365

5. Shah NG, Trivedi TI, Tankshali RA, Goswami JA, Shah JS, Jetly DH, Kobawala TP, Patel KC, Shukla SN, Shah PM, Verma RJ. Molecular alterations in oral carcinogenesis: Significant risk predictors in malignant transformation and tumor progression Int J Biol Markers. 2007;22:132–43.

PMid:17549669

6. Engel H, Huang JJ, Lin CY, Lam W, Kao HK, Gazyakan E, Cheng MH. A Strategic approach for tongue reconstruction to achieve predictable and improved functional and aesthetic outcomes. Plast Reconstr Surg. 2010;126:1967-77.

http://dx.doi.org/10.1097/PRS.0b013e3181f44742

PMid:21124135

7. Pazardzhikliev DD, Shipkov CD, Yovchev IP, Khater RH, Kamishev IS. Functional reconstruction of subtotal glossectomy defects with radial forearm free flap: case report and review of literature. Folia Med (Plovdiv). 2012;54:60-5.

http://dx.doi.org/10.2478/v10153-011-0090-x

PMid: 23101287

8. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.

PMid:8558223